Axsome Therapeutics to Participate in Upcoming Investor Conferences
Provided By GlobeNewswire
Last update: May 29, 2025
NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will participate in three upcoming investor conferences in June:
Read more at globenewswire.com
